The remission of post-transplant nephrotic syndrome clinicopathologic characterization

American Journal of Transplantation

Volumn 2, Issue 10, 2002, Pages 975-982

  Truong, Luan D ^a   Baranowska Daca, Elzbieta ^a   Ly, Peter Danh Cong ^a   Tsao, Chun Chui ^a   Zafarmand, Alireza Atef ^a   Suki, Wadi N ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Acute glomerulitis; Chronic transplant nephropathy; De novo minimal change disease; IgA nephropathy; Post transplant nephrotic syndrome; Remission

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; STEROID;

ARTICLE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; POSTOPERATIVE COMPLICATION; REMISSION;

ADULT; BIOPSY; CADAVER; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0036871372     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.21016.x     Document Type: Article

References (49)

1. Cheigh JS, Mouradian J, Susin M et al. Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural course. Kidney Int 1980; 18: 358-365.
2. First MR, Vaidya PN, Maryniak RK et al. Proteinuria following transplantation. Transplantation 1984; 38: 607-612.
3. Fontaine MP, Rodriguez-Carmona A, Falcon TG, Valdes F. Early proteinuria in renal transplant recipients treated with cyclosporin. Transplantation 1999; 67: 561-568.
4. Kim HC, Park SB, Lee SH, Park KK, Park CH, Cho WH. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance. Transplant Proc 1994; 26: 2134-2135.
5. Park JH, Park JH, Bok HJ et al. Persistent proteinuria as a prognostic factor for determining long-term graft survival in renal transplant recipients. Transplant Proc 2000; 32: 1924.
6. Pedi VR, Dean DE, Hariharan S, Cavallo T, Schroeder TJ, First MR. Proteinuria following renal transplantation. Correlation with histopathology and outcome. Transplant Proc 1997; 29: 101-103.
7. Vathsala A, Verani R, Schoenberg L et al. Proteinuria in cyclosporin-treated renal transplant recipients. Transplantation 1990; 49: 35-41.
8. Yildiz A, Erkoc R, Sever MS et al. The prognostic importance of severity and type of post-transplant proteinuria. Clin Transplant 1999; 13: 241-244.
9. Laterre EC, Van Ypersele De Strihou C, Alexandre GPJ. Proteinuria in human renal allograft with special reference to glomerular permeability in acute renal rejection crises. In: Manuel Y, Revillard JP, Betnel H, eds. Proteins in Normal and Pathological Urine. New York: Karger Basel; 1970. pp 300-308.
10. Sethi K, First MR, Pesce AJ, Fidler JP, Pollak VE. Proteinuria following renal transplantation. Nephron 1977; 18: 49-59.
11. Revillard JP, Manuel Y, Betuel H, Fries D, Traeger J. Proteinuria in human renal allografts. Sequential studies. In: Manuel Y, Revillard JP, Betnel H, eds. Proteins in Normal and Pathological Urine. New York: Karger Basel: 1970. pp 300-308.
12. Yanagisawa T, Kuzuhara K, Nishimori S et al. Clinical significance of albuminuria in renal transplantation. Transplant Proc 1994; 26: 2174-2175.
13. Fujita Y, Mori I, Kitano S. Determination of proteins by using the color reaction with pyrocatechol violet-molybdenum (VI) complex. Chem Pharm Bull 1984; 32: 4161-4164.
14. Saudan PJ, Brown MA, Farrell T, Shaw L. Improved methods of assessing proteinuria in hypertensive pregnancy. Br J Obstet Gynaecol 1997; 104: 1159-1164.
15. Zelmanovitz T, Gross JL, Oliveira J, de Azevedo MJ. Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy. Diabetes Care 1998; 21: 1076-1079.
16. Ruggenenti P, Gaspari F, Perna A, Remuzzi G. Cross sectional longitudinal study of spot morning urine protein: creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. Br Med J 1998; 316: 504-509.
17. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
18. Markowitz GS, Craig LS, Croker BP, D'Agati VD. De novo minimal change disease. Am J Kidney Dis 1998; 32: 508-513.
19. Abouna GM, Kogure H, Porter KA, Andres GA, Lutcher CL, Sobel RE. Massive early proteinuria following renal homotransplantation. JAMA 1973; 226: 631-635.
20. Mauer SM, Hellerstein S, Cohn RA, Sibley RK, Vernier RL. Recurrence of steroid-responsive nephrotic syndrome after renal transplantation. J Pediatr 1979; 95: 261-264.
21. McLeish KR, Gohara AF, Shapiro RS. Massive post-transplant proteinuria with minimal histological changes. Transplantation 1980; 29: 392-396.
22. Shapiro RS, Deshmukh A, Kropp K. Massive post-transplant proteinuria. Biopsy-proven nil disease. Transplantation 1976; 22: 489-492.
23. Lane PH, Schnaper HW, Vernier RL, Bunchman TE. Steroid-dependent nephrotic syndrome following renal transplantation for congenital nephrotic syndrome. Pediatr Nephrol 1991; 5: 300-333.
24. Flynn JT, Schulman SL, de Chadarevian JP et al. Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome. Pediatr Nephrol 1992; 6: 553-555.
25. Habib R, Antignac C, Hinglais N, Gagnadou M-F, Broyer M. Glomerular lesions in the transplanted kidney in children. Am J Kidney Dis 1987; 10: 198-207.
26. Ahmad I, Abull-Ezz SR, Walker P, Bonsib S, Ketel B, Barri Y. Acute rejection presenting as nephrotic syndrome. Transplantation 2000; 69: 2663-2665.
27. Monga G, Mazzucco G, Basolo B et al. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol 1998; 6: 249-259.
28. Morales JM, Pascual-Capdevila J, Campistol JM et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997; 63: 1634-1639.
29. Marcen R, Mampaso F, Teruel JL et al. Membranous nephropathy: recurrence after kidney transplantation. Nephrol Dial Transplant 1996; 11: 1129-1133.
30. Zanetta G, Maurice-Estepa L, Mousson C et al. Foscarnet-induced crystalline glomerulonephritis with nephrotic syndrome and acute renal failure after kidney transplantation. Transplantation 1999; 67: 1376-1378.
31. Cheong HI, Han HW, Park HW et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000; 15: 78-81.
32. Artero M, Biava C, Amend W, Tomlanovitch S, Vincent F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375-383.
33. Wuhl E, Fydryk J, Wiesel M, Tomlanovitch S, Vincenti F. Impact of recurrent nephrotic syndrome after renal transplantation in young patients. Pediatr Nephrol 1998; 12: 529-533.
34. Gephardt GN, Tubbs RR, Braun WE, Novick AC, McMahon JT, Steinmuller DR. Nephrotic range proteinuria with 'minimal change glomerulopathy' in human renal allografts: report of four cases. Am J Kidney Dis 1988; 12: 51-61.
35. Esparza AR, Hahn SI, Garella S, Abuelo JG. Spectrum of acute renal failure in nephrotic syndrome with minimal (or minor) glomerular lesions: role of hemodynamic factors. Lab Invest 1981; 45: 510-516.
36. Garin EH, Self SE. The effect of lymphocytes from renal transplant patients on glomerular basement membrane uptake. Pediatr Nephrol 1995; 9: 3313-3316.
37. Truong L, Gelfand J, d'Agati V et al. De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature. Am J Kidney Dis 1989; 24: 131-144.
38. Ward HJ, Koyle MA. Immunopathologic features of de novo membranous nephropathy in renal allografts. Transplantation 1988; 45: 524-529.
39. Johnson PA, Goode NP, Aparicio SR, Davison AM. Membranous allograft nephropathy. Remission of nephrotic syndrome with pulsed methylprednisolone and high dose alternative-day steroid. Transplantation 1993; 55: 214-215.
40. Frohnert PP, Donadio JV, Velosa JA, Hollet KE, Sterioff S. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 1997: 11: 127-133.
41. Bumgardner GL, Amend WC, Ascher NL, Vincent FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998; 65: 1053-1106.
42. Tuazon TV, Schneeberger EE, Bhan AK et al. Mononuclear cells in acute allograft glomerulopathy. Am J Pathol 1987; 129: 119-132.
43. Verani RR, Bergman D, Kerman RH. Glomerulopathy in acute and chronic rejection: relationship of ultrastructure to graft survival. Am J Nephrol 19B3; 3: 253-263.
44. Habib R, Broyer M. Clinical significance of allograft glomerulopathy. Kidney Int 1993; 44: S95-S98.
45. Hibberd AD, Nanra RS, White KH, Trevillian PR. Reversal of acute glomerular renal allograft rejection: a possible effect of OKT3. Transplant Int 1991; 1: 246-249.
46. Onitsuka S, Yamaguchi Y, Toma H et al. Glomerular rejection in kidney allografts under cyclosporin. Transplant Proc 1989; 21: 1680-1682.
47. Calvino J, Lens XM, Romero R, Sanchez-Guisande D. Long-term antiproteinuric effect of Losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant 2000; 15: 82-86.
48. Mehrens T, Thiele S, Suwelack B, Kemples M, Hohage H. The beneficial effects of calcium channel blockers on long-term kidney transplant survival are independent of blood-pressure reduction. Clin Transplant 2000; 14: 257-261.
49. 1) receptor antagonists in the treatment of hypertension after renal transplantation. Nephrol Dial Transplant 2001; 16 (Suppl. 1): 117-120.